Supreme Court rejects bid to restrict access to abortion pill mifepristone

The Supreme Court on Thursday rejected a challenge to the abortion pill mifepristone, meaning the commonly used drug can remain widely available, according to NBC News.

The high court found unanimously that the group of anti-abortion doctors that questioned the Food and Drug Administration's decisions making it easier to access the pill lacked legal standing to sue, according to NBC News. 

The 9-0 decision did not address the group's underlying legal argument about whether the FDA acted lawfully in lifting various restrictions, including one making the drug obtainable via mail. As a result, the issues could return to the court in another case.

Another regulatory decision left in place means women can still obtain the pill within 10 weeks of gestation instead of seven, NBC News also reports.

The ruling comes two years after the conservative-leaning court overturned the landmark abortion rights decision Roe v. Wade, which led to new abortion restrictions in conservative states.